CA
NZ
UK
AU
IND
US
NeuroOne Medical Technologies Corporation (NASDAQ:NMTC), a small medical-device company developing thin-film electrode technology for recording, ablation and drug delivery, has faced pressure in the market despite growing revenue, largely because manufacturing constraints have forced it to lower guidance and its cash position has thinned. …
Jasper Therapeutics, Inc. (NASDAQ:JSPR), a clinical-stage biotechnology company developing its antibody briquilimab across allergic and inflammatory diseases, saw its shares slide even as it attracted a bullish analyst stance and reported updated data supporting dose selection ahead of a pivotal-style study. The decline raises …
LifeMD, Inc. (NASDAQ:LFMD), a direct-to-patient telehealth company, has gone quiet in the market during a transitional period defined by its shift toward branded GLP-1 weight-management therapies. The changeover has pressured near-term results even as its subscriber base grows, leaving investors to weigh whether the …
Evolent Health, Inc. (NYSE:EVH), a company that partners with health plans and providers to manage specialty care through value-based arrangements, delivered rapid revenue growth and raised its full-year outlook, yet its shares dropped as investors focused on the margin pressure from rising medical costs. …
Akari Therapeutics Plc (NASDAQ:AKTX), a clinical-stage biotechnology company, has seen its thinly traded shares move higher, a reminder of how quickly sentiment can shift in small-cap biotech. But investors examining Akari today should understand that it is a very different company than it was …
CalciMedica, Inc. (NASDAQ:CALC), a clinical-stage biotechnology company developing therapies that target calcium-release-activated calcium (CRAC) channels, saw its shares plunge sharply even as it works to recalibrate its pipeline and line up the financing to advance its lead asset. The scale of the drop underscores …
Cerenome, Inc. (NASDAQ:CNSY) is a small clinical-stage company focused on cancers of the central nervous system, developing a radiotherapy candidate while commercializing a diagnostic test, and its stock gained ground even amid the challenges facing micro-cap biotechs. Recently rebranded from Plus Therapeutics, the company …
Citius Oncology, Inc. (NASDAQ:CTOR), a company commercializing an approved cancer immunotherapy, has seen its stock slide even as it reports building commercial momentum for its lead product. The company launched LYMPHIR for a form of lymphoma and has been growing its customer base, leaving …
Cognition Therapeutics, Inc. (NASDAQ:CGTX) is a clinical-stage biotech developing zervimesine (CT1812), an oral drug for neurodegenerative diseases, and the stock ticked higher as the company advances its programs in dementia with Lewy bodies and Alzheimer's disease. With encouraging Phase 2 data and plans for …
AirSculpt Technologies, Inc. (NASDAQ:AIRS), a provider of body-contouring and cosmetic procedures through a network of clinics, saw its stock fall after a soft second quarter, as investors weigh the company's differentiated procedures against near-termDemandand profitability pressures. AirSculpt reported a revenue decline and lowered part …
Please wait processing your request...